SEC Form 13F

DCF Advisers, LLC 13F Holdings

Inspect DCF Advisers, LLC's 2026-06-30 SEC 13F positions, public filing date, amendments and original receipt.

As of 2026-08-11T03:59:59.999Z

Report period
2026-06-30
Publicly available
2026-08-11
Reported value
$565,758,923
Positions
93

Disclosed positions

INVESCO QQQ TRQQQUNIT SER 1$142,198,840193,100SHPut
MICRON TECHNOLOGY INCMUCOM$115,429,000100,000SHNone
ALPHABET INCGOOGCAP STK CL C$19,079,82054,000SHNone
STATE STR SPDR S&P 500 ETF TSPYTR UNIT$18,669,25025,000SHPut
ADVANCED MICRO DEVICES INCAMDCOM$16,846,39029,000SHNone
MICRON TECHNOLOGY INCMUCOM$14,428,62512,500SHCall
AMAZON COM INCAMZNCOM$14,121,64559,250SHNone
ARGENX SEARGXSPONSORED ADR$13,174,33414,200SHNone
CORVUS PHARMACEUTICALS INCCRVSCOM$9,524,250637,500SHNone
CYBIN INCHELPCOM NEW$9,485,2711,434,988SHNone
TEVA PHARMACEUTICAL INDS LTDTEVASPONSORED ADS$8,622,460254,500SHNone
MARVELL TECHNOLOGY INCMRVLCOM$8,191,97527,500SHNone
ISHARES GOLD TRIAUISHARES NEW$7,551,000100,000SHNone
BANK OF AMER CORPBACCOM$6,809,110119,500SHNone
REGENERON PHARMACEUTICALSREGNCOM$5,767,7459,250SHNone
ENERGY TRANSFER L PETCOM UT LTD PTN$5,745,560300,500SHNone
VERTEX PHARMACEUTICALS INCVRTXCOM$5,712,39511,500SHNone
SPDR GOLD TRGLDGOLD SHS$5,157,32014,000SHNone
CITIGROUP INCCCOM NEW$5,038,56036,000SHNone
NEWAMSTERDAM PHARMA COMPANYNAMSORDINARY SHARES$4,778,490141,000SHNone
VANECK ETF TRUSTGDXGOLD MINERS ETF$4,715,62562,500SHNone
INCYTE CORPINCYCOM$4,704,44041,500SHNone
CISCO SYS INCCSCOCOM$4,698,40040,000SHNone
BAIDU INCBIDUSPON ADR REP A$4,571,60040,000SHNone
ORACLE CORPORCLCOM$4,469,77530,500SHNone
ZOOM COMMUNICATIONS INCZMCL A$4,391,02150,875SHNone
INTEL CORPINTCCOM$3,979,45528,500SHNone
IMMUNEERING CORPIMRXCLASS A COM$3,942,100790,000SHNone
ALIBABA GROUP HLDG LTDBABASPONSORED ADS$3,791,21039,500SHNone
MICROSOFT CORPMSFTCOM$3,627,6209,725SHNone
UBER TECHNOLOGIES INCUBERCOM$3,608,00050,000SHNone
LAM RESEARCH CORPLRCXCOM NEW$3,249,9757,500SHNone
ELI LILLY & COLLYCOM$3,238,4612,700SHNone
EVOTEC AGEVOSPONSORED ADS$3,021,2671,079,024SHNone
IONIS PHARMACEUTICALS INCIONSCOM$2,973,37537,500SHNone
ABRDN TOTAL DYNAMIC DIVIDENDAODCOM SH BEN INT$2,742,460266,000SHNone
ABBVIE INCABBVCOM$2,705,13010,750SHNone
BROADCOM INCAVGOCOM$2,691,4697,125SHNone
ZIMMER BIOMET HOLDINGS INCZBHCOM$2,625,74530,500SHNone
NUVEEN CR STRATEGIES INCOMEJQCCOM SHS$2,566,629528,113SHNone
VANECK ETF TRUSTGDXJJUNIOR GOLD MINE$2,456,25025,000SHNone
MICROSOFT CORPMSFTCOM$2,312,7246,200SHCall
LIFECORE BIOMEDICAL INCLFCRCOM$2,228,625424,500SHNone
BARRICK MNG CORPBCOM SHS$2,203,80060,000SHNone
ISHARES SILVER TRSLVISHARES$2,138,80040,000SHNone
MARINEMAX INCHZOCOM$2,105,65057,500SHNone
BARNES & NOBLE ED INCBNEDCOM NEW$2,064,650164,383SHNone
BIOHAVEN LTDBHVNCOM$2,001,360134,500SHCall
BIOHAVEN LTDBHVNCOM$1,934,400130,000SHNone
AMGEN INCAMGNCOM$1,901,1305,250SHNone

Largest 50 positions by reported value; the filing may contain more positions.

How amendments affect these holdings

This view uses 1 effective filing version(s). A restatement replaces the previous book; a new-holdings amendment adds positions. 1 positions lack a resolved ticker and 13 positions are put or call entries.

A 13F is a delayed quarterly snapshot of disclosed holdings. It is not a complete trade ledger and does not reveal every position in a manager's portfolio. Option values refer to the reported underlying position rather than a traded option premium.

Quarter end and public filing date

Use the filing's public availability date when constructing a historical observation. The quarter-end report period is earlier and cannot be substituted for when the public learned the holdings.